Novel Biomarkers, Oxidative Stress, and the Role of Labile Iron Toxicity in Cardiopulmonary Bypass-Associated Acute Kidney Injury

Journal of the American College of Cardiology

Volumn 55, Issue 19, 2010, Pages 2024-2033

  Haase, Michael ^a,b   Bellomo, Rinaldo ^b   Haase Fielitz, Anja ^a,b  

^a AUSTIN HEALTH   (Australia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

acute kidney injury; biomarker; labile iron

Indexed keywords

ALPHA 1 MICROGLOBULIN; BICARBONATE; BIOLOGICAL MARKER; DEFEROXAMINE; FATTY ACID BINDING PROTEIN; HAPTOGLOBIN; HEME; HEPCIDIN; IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REACTIVE OXYGEN METABOLITE;

CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DISEASE MODEL; DRUG MECHANISM; HEMODYNAMICS; HEMOLYSIS; HUMAN; INFLAMMATION; IRON OVERLOAD; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENAL PROTECTION; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; HUMANS; IRON OVERLOAD; KIDNEY FAILURE, ACUTE; OXIDATIVE STRESS;

EID: 77951634849     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.046     Document Type: Review

References (112)

1. Nicoara A., Patel U.D., Phillips-Bute B.G., et al. Mortality trends associated with acute renal failure requiring dialysis after CABG surgery in the United States. Blood Purif 28 (2009) 359-363
2. Chertow G.M., Burdick E., Honour M., Bonventre J.V., and Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005) 3365-3370
3. Coca S.G., Yusuf B., Shlipak M.G., Garg A.X., and Parikh C.R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53 (2009) 961-973
4. Kellum J.A., and Hoste E.A. Acute kidney injury: epidemiology and assessment. Scand J Clin Lab Invest Suppl 241 (2008) 6-11
5. McCullough P.A. Contrast-induced acute kidney injury. J Am Coll Cardiol 51 (2008) 1419-1428
6. Hobson C.E., Yavas S., Segal M.S., et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 119 (2009) 2444-2453
7. Aregger F., Wenaweser P., Hellige G.J., et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 24 (2009) 2175-2179
8. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294 (2005) 813-818
9. Ronco C., Haapio M., House A.A., Anavekar N., and Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 52 (2008) 1527-1539
10. Bellomo R., Auriemma S., Fabbri A., et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 31 (2008) 166-178
11. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005) 1231-1238
12. Portilla D., Dent C., Sugaya T., et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 73 (2008) 465-472
13. Devarajan P., Nguyen M., Kathman T., Wang Z., Dent C., and Parikh C. Validation of early AKI biomarkers discovered by proteomics. Free Commun J Am Soc Nephrol 19 (2008) 92A
14. Ho J., Lucy M., Krokhin O., et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Am J Kidney Dis 53 (2009) 584-595
15. Takami Y., Makinouchi K., Nakazawa T., Glueck J., Benkowski R., and Nosé Y. Effect of surface roughness on hemolysis in a pivot bearing supported Gyro centrifugal pump (C1E3). Artif Organs 20 (1996) 1155-1161
16. Tanaka K., Kanamori Y., Sato T., et al. Administration of haptoglobin during cardiopulmonary bypass surgery. ASAIO Trans 37 (1991) M482-M483
17. Kanamori Y., Tanabe H., Shimono T., et al. The effects of administration of haptoglobin for hemolysis by extracorporeal circulation. Rinsho Kyobu Geka 9 (1989) 463-467
18. Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol 40 (2008) 257-267
19. Supavekin S., Zhang W., Kucherlapati R., Kaskel F.J., Moore L.C., and Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63 (2003) 1714-1724
20. Mishra J., Ma Q., Prada A., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14 (2003) 2534-2543
21. Yang J., Goetz D., Li J.Y., et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 10 (2002) 1045-1056
22. Mishra J., Mori K., Ma Q., et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15 (2004) 3073-3082
23. Mori K., Lee H.T., Rapoport D., et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115 (2005) 610-621
24. Huynh T.K., Bateman D.A., Parravicini E., et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res 66 (2009) 528-532
25. Mishra J., Mori K., Ma Q., et al. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24 (2004) 307-315
26. Haase-Fielitz A., Bellomo R., Devarajan P., et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 37 (2009) 553-560
27. Wagener G., Jan M., Kim M., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105 (2006) 485-491
28. Dent C.L., Ma Q., Dastrala S., et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11 (2007) R127
29. Wagener G., Gubitosa G., Wang S., Borregaard N., Kim M., and Lee H.T. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 52 (2008) 425-433
30. Bennett M., Dent C.L., Ma Q., et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3 (2008) 665-673
31. Xin C., Yulong X., Yu C., Changchun C., Feng Z., and Xinwei M. Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail 30 (2008) 904-913
32. Koyner J.L., Bennett M.R., Worcester E.M., et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 74 (2008) 1059-1069
33. Lima E.D., Miranda R., Machado M., et al. Role of neutrophil gelatinase-associated lipocalin (NGAL) in the early diagnosis of acute kidney injury after cardiopulmonary bypass. J Am Soc Nephrol 19 (2008) 569A
34. Tuladhar S.M., Püntmann V.O., Soni M., Punjabi P.P., and Bogle R.G. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 53 (2009) 261-266
35. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A., and NGAL Meta-Analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54 (2009) 1012-1024
36. Kjeldsen L., Johnsen A.H., Sengeløv H., et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268 (1993) 10425-10432
37. Grigoryev D.N., Liu M., Hassoun H.T., et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 19 (2008) 547-558
38. Hvidberg V., Jacobsen C., Strong R.K., Cowland J.B., Moestrup S.K., and Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579 (2005) 773-777
39. Andrews S.C., Robinson A.K., and Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 27 (2003) 215-237
40. Fernandez-Pol J.A. Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid. Cell 14 (1978) 489-499
41. Jones R.L., Peterson C.M., Grady R.W., and Cerami A. Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J Exp Med 151 (1980) 418-428
42. Stintzi A., Barnes C., Xu J., and Raymond K.N. Microbial iron transport via a siderophore shuttle: a membrane ion transport paradigm. Proc Natl Acad Sci U S A 97 (2000) 10691-10696
43. Devireddy L.R., Gazin C., Zhu X., and Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123 (2005) 1293-1305
44. Kemna E.H.J.M., Pickkers P., Nemeth E., et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
45. Hamada Y., and Fukagawa M. Is hepcidin the star player in iron metabolism in chronic kidney disease?. Kidney Int 75 (2009) 873-874
46. Pigeon C., Ilyin G., Courselaud B., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
47. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806-7810
48. Kulaksiz H., Theilig F., Bachmann S., et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184 (2005) 361-370
49. Détivaud L., Nemeth E., Boudjema K., et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 106 (2005) 746-748
50. Weizer-Stern O., Adamsky K., Amariglio N., Breda L., Rivella S., and Rechavi G. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am J Hematol 81 (2006) 479-483
51. Weizer-Stern O., Adamsky K., Amariglio N., et al. Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera. Br J Haematol 135 (2006) 129-138
52. Zhang X., Jin M., Wu H., et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 74 (2008) 799-807
53. Rovin B.H., and Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin J Am Soc Nephrol 4 (2009) 1858-1865
54. Larsson J., Allhorn M., and Kerstrom B. The lipocalin alpha(1)-microglobulin binds heme in different species. Arch Biochem Biophys 432 (2004) 196-204
55. Allhorn M., Klapyta A., and Akerström B. Redox properties of the lipocalin alpha1-microglobulin: reduction of cytochrome C, hemoglobin, and free iron. Free Radic Biol Med 38 (2005) 557-567
56. Bernard A.M., Vyskocil A.A., Mahieu P., and Lauwerys R.R. Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 33 (1987) 775-779
57. Herget-Rosenthal S., Poppen D., and Hüsing J. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 50 (2004) 552-558
58. Ascenzi P., Bocedi A., Visca P., et al. Hemoglobin and heme scavenging. IUBMB Life 57 (2005) 749-759
59. Hofstra J.M., Deegens J.K., Steenbergen E.J., and Wetzels J.F. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy. Nephrol Dial Transplant 23 (2008) 3160-3165
60. Negishi K., Noiri E., Doi K., et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 174 (2009) 1154-1159
61. Washburn K.K., Zappitelli M., Arikan A.A., et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 23 (2008) 566-572
62. Haase M., Bellomo R., Story D., Davenport P., and Haase-Fielitz A. Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care 12 (2008) R96
63. Han W.K., Wagener G., Zhu Y., Wang S., and Lee H.T. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 4 (2009) 873-882
64. Liangos O., Tighiouart H., Perianayagam M.C., et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 14 (2009) 423-431
65. Menasche P. The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Ann Thorac Surg 72 (2001) S2260-S2265
66. Dhalla N.S., Elmoselhi A.B., Hata T., and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47 (2000) 446-456
67. Sponsel H.T., Alfrey A.C., Hammond W.S., Durr J.A., Ray C., and Anderson R.J. Effect of iron on renal tubular epithelial cells. Kidney Int 50 (1996) 436-444
68. Paller M. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 255 (1988) F539-F544
69. Davis C.L., Kausz A.T., Zager R.A., Kharasch E.D., and Cochran R.P. Acute renal failure after cardiopulmonary bypass is related to decreased serum ferritin levels. J Am Soc Nephrol 10 (1999) 2396-2402
70. Flamenbaum W. Acute renal failure associated with myoglobinuria and hemoglobinuria. In: Brenner B.M., and Lazarus J.M. (Eds). Acute Renal Failure (1983), W.B. Saunders, Philadelphia, PA 269-282
71. Zager R.A., and Gamelin L.M. Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol 256 (1989) F446-F455
72. Tam S.C., and Wong T.J. Impairment of renal function by stroma-free hemoglobin in rats. J Lab Clin Med 111 (1988) 189-193
73. Vermeulen Windsant I.C., Snoeijs M.G., Hanssen S.J., et al. Hemolysis is associated with acute kidney injury during major aortic surgery. Kidney Int (2010 Feb 24) [E-pub ahead of print]
74. Loef B.G., Epema A.H., Navis G., Ebels T., van Oeveren W., and Henning R.H. Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. Chest 121 (2002) 1190-1194
75. Tamaguchi H., Shimizu T., Akutsu H., et al. Hemolysis and red cell deformability during cardiopulmonary bypass-the effect of prostaglandin E1 for prevention of hemolysis. Nippon Kyobu Geka Gakkai Zasshi 38 (1990) 625-629
76. Hirayama T., Herlitz H., Jonsson O., and Roberts D. Deformability and electrolyte changes of erythrocytes in connection with open heart surgery. Scand J Thorac Cardiovasc Surg 20 (1986) 253-259
77. Boldt J., Brenner T., Lehmann A., Suttner S.W., Kumle B., and Isgro F. Is kidney function altered by the duration of cardiopulmonary bypass?. Ann Thorac Surg 75 (2003) 906-912
78. Fischer U.M., Weissenberger W.K., Warters R.D., Geissler H.J., Allen S.J., and Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 17 (2002) 401-406
79. Azemoto R., Tsuchiya Y., Ai T., et al. Does gallstone formation after open cardiac surgery result only from latent hemolysis by replaced valves?. Am J Gastroenterol 91 (1996) 2185-2189
80. Moat N.E., Evans T.E., Quinlan G.J., and Gutteridge J.M. Chelatable iron and copper can be released from extracorporeally circulated blood during cardiopulmonary bypass. FEBS Lett 328 (1993) 103-106
81. Keene W.R., and Jandl J.H. The sites of hemoglobin catabolism. Blood 26 (1965) 705-719
82. Gutteridge J.M. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201 (1986) 291-295
83. Flaherty J.T., and Weisfeldt M.L. Reperfusion injury. Free Radic Biol Med 5 (1988) 409-419
84. Lele S., Shah S., McCullough P.A., and Rajapurkar M. Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes. EuroIntervention 5 (2009) 336-342
85. Idriss N.K., Blann A.D., and Lip G.Y. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 52 (2008) 971-978
86. Balogun E., Foresti R., Green C.J., and Motterlini R. Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells. Biochem Biophys Res Commun 308 (2003) 950-955
87. Hill-Kapturczak N., Chang S.H., and Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol 21 (2002) 307-321
88. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186 (1990) 1-85
89. Feola M., Simoni J., Tran R., and Canizaro P.C. Nephrotoxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 18 (1990) 233-249
90. Lehotsky J., Kaplán P., Matejovicová M., Murín R., Racay P., and Raeymaekers L. Ion transport systems as targets of free radicals during ischemia reperfusion injury. Gen Physiol Biophys 21 (2002) 31-37
91. Karkouti K., Wijeysundera D.N., Yau T.M., et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 119 (2009) 495-502
92. Das D.K., Engelman R.M., Liu X., et al. Oxygen-derived free radicals and hemolysis during open heart surgery. Mol Cell Biochem 111 (1992) 77-86
93. Haase M., Haase-Fielitz A., Bagshaw S.M., Ronco C., and Bellomo R. Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy?. Contrib Nephrol 156 (2007) 340-353
94. Atkins J.L. Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron 44 (1986) 70-74
95. Gladwin M.T., Crawford J.H., and Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 36 (2004) 707-717
96. Loebl E.C., Baxter C.R., and Curreri P.W. The mechanism of erythrocyte destruction in the early post-burn period. Ann Sur 178 (1973) 681-686
97. Pepper J.R., Mumby S., and Gutteridge J.M. Sequential oxidative damage, and changes in iron-binding and iron-oxidising plasma antioxidants during cardiopulmonary bypass surgery. Free Radic Res 21 (1994) 377-385
98. Pepper J.R., Mumby S., and Gutteridge J.M. Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass. Ann Thorac Surg 60 (1995) 1735-1740
99. Menasché P., Antebi H., Alcindor L.G., et al. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation 82 (1990) IV390-IV396
100. Nath K.A., and Norby S.M. Reactive oxygen species and acute renal failure. Am J Med 109 (2000) 665-678
101. Doi K., Suzuki Y., Nakao A., Fujita T., and Noiri E. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 65 (2004) 1714-1723
102. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159-163
103. Baliga R., Ueda N., Walker P.D., and Shah S.V. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31 (1999) 971-997
104. Ohshiro T., Mukai K., and Kosaki G. Prevention of hemoglobinuria by administration of haptoglobin. Res Exp Med (Berl) 177 (1980) 1-12
105. Yoshioka T., Sugimoto T., Ukai T., and Oshiro T. Haptoglobin therapy for possible prevention of renal failure following thermal injury: a clinical study. J Trauma 25 (1985) 281-287
106. Shah S., and Walker P.D. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 255 (1988) F438-F443
107. Shah S. Role of iron in progressive renal disease. Am J Kidney Dis 37 (2001) S30-S33
108. Aigner F., Maier H.T., Schwelberger H.G., et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 7 (2007) 779-788
109. Haase M., Haase-Fielitz A., Bellomo R., et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 37 (2009) 39-47
110. Cohen G. The Fenton reaction. In: Greenwald R.A. (Ed). CRC Handbook of Methods for Oxygen Radical Research (1985), CRC Press, Boca Raton, FL 5564
111. Caulfield J.L., Singh S.P., Wishnok J.S., Deen W.M., and Tannenbaum S.R. Bicarbonate inhibits N-nitrosation in oxygenated nitric oxide solutions. J Biol Chem 271 (1996) 25859-25863
112. Hingorani S., Molitoris B.A., and Himmelfarb J. Ironing out the pathogenesis of acute kidney injury. Am J Kidney Dis 53 (2009) 569-571